Response to: COVID-19-associated mucormycosis and evolving evidence.

Sarda, R; Swain, S; Ray, A; Wig, N

Sarda, R; Swain, S; Ray, A; Wig, N.

Afiliação

Sarda R; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Swain S; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Ray A; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.
Wig N; From the Department of Medicine, All India Institute of Medical Sciences, Room no: 3070A, 3rd Floor Teaching Block, Ansari Nagar, New Delhi 110029, India.

QJM ; 115(6): 422, 2022 06 07.

Article em En | MEDLINE | ID: mdl-34264346

Assuntos

COVID-19; Mucormicose; Humanos; Mucormicose/complicações; Mucormicose/diagnóstico; Fatores de Risco; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Mucormicose Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google